XML 77 R37.htm IDEA: XBRL DOCUMENT v3.24.0.1
Equity (Tables)
 12 Months Ended
Dec. 31, 2023
Stockholders' Equity Note [Abstract]  
Schedule of reconciliation of common stock share activity
Common stock share activity for 2023, 2022 and 2021 is as follows:
(Shares of common stock, in thousands)IssuedHeld in TreasuryOutstanding
Balance at December 31, 202077,81110,79567,016
Issuance of restricted stock units as compensation—(69)69
Performance shares and other share-based awards—(6)6
Stock options exercised—(331)331
Purchase/acquisition of treasury stock—765(765)
Balance at December 31, 202177,81111,15466,657
Issuance of restricted stock units as compensation—(95)95
Performance shares and other share-based awards—(43)43
Stock options exercised—(182)182
Purchase/acquisition of treasury stock—1,283(1,283)
Balance at December 31, 202277,81112,11765,694
Issuance of restricted stock units as compensation—(108)108
Performance shares and other share-based awards—(51)51
Stock options exercised—(386)386
Purchase/acquisition of treasury stock—1,000(1,000)
Balance at December 31, 202377,81112,57265,239
Schedule of stock based compensation expense Share-based compensation expense for 2023, 2022 and 2021 is as follows:
202320222021
Stock options:
Pre-tax compensation expense$4 $4 $3 
Income tax benefit— — — 
Stock option expense, net of income taxes4 4 3 
Restricted stock units (“RSUs”):
Pre-tax compensation expense15 13 12 
Income tax benefit(2)(1)(1)
RSUs, net of income taxes13 12 11 
Performance shares and other share-based awards:
Pre-tax compensation expense14 12 8 
Income tax benefit(1)(1)(1)
Performance shares and other share-based compensation expense, net of income taxes13 11 7 
Total share-based compensation:
Pre-tax compensation expense33 29 23 
Income tax benefit(3)(2)(2)
Total share-based compensation expense, net of income taxes$30 $27 $21 
Schedule of valuation assumptions for stock options The fair value of each option grant was estimated using the Black-Scholes option-pricing model with the following assumptions:
For the Year Ended December 31,
202320222021
Expected life (in years)5.55.55.5
Risk-free interest rate4.0 %2.0 %0.6 %
Expected volatility28.3 %23.8 %23.2 %
Expected dividend yield2.9 %2.9 %2.9 %
Schedule of stock option transactions
Stock option activity in 2023 is as follows:
Number of Options
(in thousands)		Weighted Average Exercise Price per ShareAverage Remaining Contractual Term (Years)Aggregate Intrinsic Value
(in millions)
Outstanding as of December 31, 20222,222$92.32 5.16$24 
Granted19798.69 
Exercised(386)71.76 
Cancelled(80)102.66 
Outstanding as of December 31, 20231,953$96.61 4.97$29 
Exercisable as of December 31, 20231,523$97.80 4.03$22 
Schedule of additional information pertaining to stock option activity
Additional information pertaining to stock option activity is as follows:
Year Ended December 31,
202320222021
Weighted average grant date fair value of stock options granted (per share)$23.80 $15.04 $12.31 
Total intrinsic value of stock options exercised13 6 10 
Schedule of restricted unit activity
RSU activity in 2023 is as follows:
(shares in thousands)Number of
Restricted
Shares		Weighted
Average
Fair Value
per Share
Non-vested at December 31, 2022517$88.04 
Granted22298.15 
Vested(154)87.91 
Cancelled(33)91.30 
Non-vested at December 31, 2023552$92.05 
Summary of net changes in accumulated other comprehensive loss A summary of Accumulated other comprehensive loss for 2023, 2022 and 2021 is presented below:
Cumulative Translation AdjustmentHedging ActivitiesPension and Postretirement AdjustmentAOCL
Balance, December 31, 2020$(1,114)$42 $(61)$(1,133)
Other comprehensive (loss) income before reclassification adjustments (100)218 28 146 
Loss (income) reclassified from accumulated other comprehensive loss311 (209)— 102 
Tax (provision)— (3)(9)(12)
Net other comprehensive income211 6 19 236 
Balance, December 31, 2021(903)48 (42)(897)
Other comprehensive (loss) income before reclassification adjustments (105)210 (5)100 
(Income) reclassified from accumulated other comprehensive loss— (268)— (268)
Tax benefit— 16 1 17 
Net other comprehensive (loss)(105)(42)(4)(151)
Balance, December 31, 2022(1,008)6 (46)(1,048)
Other comprehensive income (loss) before reclassification adjustments 47 (151)(2)(106)
Loss reclassified from accumulated other comprehensive loss— 78 1 79 
Tax benefit— 19 — 19 
Net other comprehensive income (loss)47 (54)(1)(8)
Balance, December 31, 2023$(961)$(48)$(47)$(1,056)
Schedule of basic and diluted earnings per common share The following table provides the computation of basic and diluted earnings per common share (“EPS”).
202320222021
Net Income
Available
to Ingredion		Weighted
Average
Shares		Per
Share
Amount		Net Income
Available
to Ingredion		Weighted
Average
Shares		Per
Share
Amount		Net Income
Available
to Ingredion		Weighted
Average
Shares		Per
Share
Amount
Basic EPS$643 66.0$9.74 $492 66.2$7.43 $117 67.1$1.74 
Effect of Dilutive Securities:
Incremental shares from assumed exercise of dilutive stock options and vesting of dilutive RSUs and other awards1.00.80.7
Diluted EPS$643 67.0$9.60 $492 67.0$7.34 $117 67.8$1.73